Skip to content
Kalpvruksh Markets
Offline Log in

SMTNSEOffline

Sahajanand Medical · INE356Y01018
487.75+1.85 (+0.38%)last close · 05 Nov 2026
Prev close
485.90
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
—

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

SMT. Now under exchange surveillance.

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • ASM short-term 1

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
0.4×
median 7,39,323
Delivered
2,63,097
Of volume
22%

Trading restrictions

Under surveillance
ASM short-term 1 (2026-11-13)

Price & trend

Price & trend

Not enough price historyFigures need 60 sessions of NSE prices.

Ownership

Which funds bought and sold

No fund holds this companyNo Indian mutual fund disclosed a position at the last quarter end.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Credit rating
    Sahajanand Medical Technologies Limited has informed the Exchange about Credit Rating
    04 Nov 2026
  • Insider trade
    Sahajanand Medical Technologies Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015'.
    23 Oct 2026
  • Bulk deal: SELL
    5,55,833 at ₹508.54 — JUMP TRADING FINANCIAL INDIA PRIVATE LIMITED
    28 Oct 2026
  • Bulk deal: SELL
    5,75,186 at ₹502.01 — MICROCURVES TRADING PRIVATE LIMITED
    28 Oct 2026
  • Bulk deal: SELL
    7,19,743 at ₹508.15 — ALPHAGREP SECURITIES PRIVATE LIMITED
    28 Oct 2026
  • Bulk deal: BUY
    5,69,867 at ₹515.65 — JUMP TRADING FINANCIAL INDIA PRIVATE LIMITED
    28 Oct 2026

Latest shown; 7 in six months on all disclosures.

SMT: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.